Blue Matter Blog
September 20, 2018
Part One in a Six-Part Series on Oncology Product Commercialization The oncology market continues to grow at a phenomenal pace, with worldwide revenues expected to increase from $104B in 2017 to $233B in 20241. Fueling this revenue growth is a rich pipeline, with more than 700 molecules in late-stage development – a 60% increase from …
By pressing the “Accept Cookies” button, the user accepts all Cookies on the Website. View our Cookie Statement.